- Report
- June 2025
- 235 Pages
Global
From €2149EUR$2,450USD£1,844GBP
- Report
- May 2025
- 186 Pages
Global
From €3109EUR$3,545USD£2,669GBP
€3455EUR$3,939USD£2,965GBP
- Report
- January 2025
- 143 Pages
Global
From €2630EUR$2,999USD£2,257GBP
- Report
- May 2025
- 193 Pages
Global
From €3109EUR$3,545USD£2,669GBP
€3455EUR$3,939USD£2,965GBP
- Report
- May 2025
- 189 Pages
Global
From €3109EUR$3,545USD£2,669GBP
€3455EUR$3,939USD£2,965GBP
- Report
- May 2025
- 186 Pages
Global
From €3109EUR$3,545USD£2,669GBP
€3455EUR$3,939USD£2,965GBP
- Report
- July 2025
- 276 Pages
Global
From €5131EUR$5,850USD£4,404GBP
- Report
- July 2025
- 474 Pages
Global
From €5131EUR$5,850USD£4,404GBP
- Report
- March 2025
- 200 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- January 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- January 2025
- 175 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- July 2025
- 463 Pages
Global
From €5131EUR$5,850USD£4,404GBP
- Report
- July 2025
- 186 Pages
Global
From €5131EUR$5,850USD£4,404GBP
- Report
- August 2024
- 182 Pages
Global
From €3355EUR$3,825USD£2,879GBP
€3947EUR$4,500USD£3,387GBP
- Report
- March 2025
- 250 Pages
Global
From €3938EUR$4,490USD£3,380GBP
- Report
- May 2025
- 116 Pages
Global
From €4166EUR$4,750USD£3,576GBP
- Report
- July 2024
- 158 Pages
Global
From €3728EUR$4,250USD£3,199GBP
- Report
- June 2023
- 158 Pages
Global
From €5219EUR$5,950USD£4,479GBP
- Report
- July 2023
- 165 Pages
Global
From €5219EUR$5,950USD£4,479GBP
- Report
- February 2024
- 119 Pages
Global
From €4166EUR$4,750USD£3,576GBP

Benign Prostatic Hyperplasia (BPH) is a common condition in men over the age of 50, where the prostate gland enlarges and causes urinary symptoms. It is a major concern in Urology and Nephrology, as it can lead to complications such as urinary retention, bladder stones, and even kidney failure. Treatment options for BPH include lifestyle changes, medications, and minimally invasive procedures.
The BPH market is composed of a variety of products and services, including medications, medical devices, and surgical procedures. Medications used to treat BPH include alpha-blockers, 5-alpha reductase inhibitors, and anticholinergics. Medical devices used to treat BPH include transurethral resection of the prostate (TURP) and transurethral microwave thermotherapy (TUMT). Surgical procedures used to treat BPH include open prostatectomy and laparoscopic prostatectomy.
Some companies in the BPH market include Allergan, Boston Scientific, Medtronic, and Urovant Sciences. Show Less Read more